These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31126238)

  • 1. Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report.
    Fraga M; Gouttenoire J; Sahli R; Chtioui H; Marcu C; Pascual M; Moradpour D; Vionnet J
    BMC Gastroenterol; 2019 May; 19(1):76. PubMed ID: 31126238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
    Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
    Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The challenge of chronic hepatitis E in liver transplant recipients: Failure of sofosbuvir plus ribavirin therapy.
    Sastre L; García-López M; Pérez-Del-Pulgar S; Lens S; Costa J; Navasa M; Forns X
    Gastroenterol Hepatol; 2020 Mar; 43(3):136-137. PubMed ID: 31902599
    [No Abstract]   [Full Text] [Related]  

  • 4. Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin.
    Biliotti E; Franchi C; Spaziante M; Garbuglia AR; Volpicelli L; Palazzo D; De Angelis M; Esvan R; Taliani G
    Infection; 2018 Oct; 46(5):725-727. PubMed ID: 29946850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
    Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
    Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report.
    Vionnet J; Pascual M; Chtioui H; Giostra E; Majno PE; Decosterd LA; Moradpour D
    BMC Gastroenterol; 2015 Mar; 15():38. PubMed ID: 25887762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribavirin for chronic hepatitis E virus infection in transplant recipients.
    Kamar N; Izopet J; Tripon S; Bismuth M; Hillaire S; Dumortier J; Radenne S; Coilly A; Garrigue V; D'Alteroche L; Buchler M; Couzi L; Lebray P; Dharancy S; Minello A; Hourmant M; Roque-Afonso AM; Abravanel F; Pol S; Rostaing L; Mallet V
    N Engl J Med; 2014 Mar; 370(12):1111-20. PubMed ID: 24645943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.
    Donato MF; Morelli C; Romagnoli R; Invernizzi F; Mazzarelli C; Iemmolo RM; Montalbano M; Lenci I; Bhoori S; Pieri G; Berardi S; Caraceni P; Martini S;
    Liver Int; 2017 May; 37(5):678-683. PubMed ID: 27865034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sofosbuvir and Ribavirin Eradication of Refractory Hepatitis E in an Immunosuppressed Kidney Transplant Recipient.
    Drinane M; Jing Wang X; Watt K
    Hepatology; 2019 May; 69(5):2297-2299. PubMed ID: 30549275
    [No Abstract]   [Full Text] [Related]  

  • 10. Sofosbuvir and Simeprevir for Treatment of Recurrent Hepatitis C Infection After Liver Transplant.
    Nair S; Satapathy SK; Gonzalez HC
    Exp Clin Transplant; 2017 Jun; 15(3):314-319. PubMed ID: 26926117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
    Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
    Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course and treatment of chronic hepatitis E virus infection in lung transplant recipients.
    Pischke S; Greer M; Hardtke S; Bremer B; Gisa A; Lehmann P; Haverich A; Welte T; Manns MP; Wedemeyer H; Gottlieb J;
    Transpl Infect Dis; 2014 Apr; 16(2):333-9. PubMed ID: 24438577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hepatitis E virus infection in a cirrhotic patient: A case report.
    Barragué H; Condat B; Petitdidier N; Champagne E; Renou C; Izopet J; Abravanel F
    Medicine (Baltimore); 2017 Sep; 96(39):e7915. PubMed ID: 28953614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-reported outcomes with sofosbuvir and velpatasvir with or without ribavirin for hepatitis C virus-related decompensated cirrhosis: an exploratory analysis from the randomised, open-label ASTRAL-4 phase 3 trial.
    Younossi ZM; Stepanova M; Charlton M; Curry MP; O'Leary JG; Brown RS; Hunt S
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):122-132. PubMed ID: 28404069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.
    Tang L; Ward H; Kattakuzhy S; Wilson E; Kottilil S
    Expert Rev Gastroenterol Hepatol; 2016; 10(1):21-36. PubMed ID: 26558305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
    Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
    Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease.
    Charlton M; Everson GT; Flamm SL; Kumar P; Landis C; Brown RS; Fried MW; Terrault NA; O'Leary JG; Vargas HE; Kuo A; Schiff E; Sulkowski MS; Gilroy R; Watt KD; Brown K; Kwo P; Pungpapong S; Korenblat KM; Muir AJ; Teperman L; Fontana RJ; Denning J; Arterburn S; Dvory-Sobol H; Brandt-Sarif T; Pang PS; McHutchison JG; Reddy KR; Afdhal N;
    Gastroenterology; 2015 Sep; 149(3):649-59. PubMed ID: 25985734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sofosbuvir and ribavirin in acute hepatitis C-infected patient with decompensated cirrhosis.
    Liu H; Zhang T; Yan Y
    Medicine (Baltimore); 2016 Dec; 95(49):e5555. PubMed ID: 27930559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M; Gane E; Manns MP; Brown RS; Curry MP; Kwo PY; Fontana RJ; Gilroy R; Teperman L; Muir AJ; McHutchison JG; Symonds WT; Brainard D; Kirby B; Dvory-Sobol H; Denning J; Arterburn S; Samuel D; Forns X; Terrault NA
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
    Manns M; Samuel D; Gane EJ; Mutimer D; McCaughan G; Buti M; Prieto M; Calleja JL; Peck-Radosavljevic M; Müllhaupt B; Agarwal K; Angus P; Yoshida EM; Colombo M; Rizzetto M; Dvory-Sobol H; Denning J; Arterburn S; Pang PS; Brainard D; McHutchison JG; Dufour JF; Van Vlierberghe H; van Hoek B; Forns X;
    Lancet Infect Dis; 2016 Jun; 16(6):685-697. PubMed ID: 26907736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.